ABOUT US

Latima Ltd. was founded on December 2, 1992.

Latima Ltd is a private company developing biotechnology using oncolytic viruses. The core elements of the company's strategy are the production of the ECHO-7 virus Rigvir, new product development, contract-manufacturing of final products and product licensing.

Latima Ltd owns a GMP certified ECHO-7 virus active substance laboratory (Cert. No. ZVA/LV/2020/006A).